Hyundai Pharm - Asset Resilience Ratio

Latest as of February 2026: 0.12%

Hyundai Pharm (004310) has an Asset Resilience Ratio of 0.12% as of February 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Hyundai Pharm to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩276.63 Million

≈ $187.47K USD Cash + Short-term Investments

Total Assets

₩224.31 Billion

≈ $152.01 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Hyundai Pharm's Asset Resilience Ratio has changed over time. See 004310 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Hyundai Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 004310 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩276.63 Million	0.12%
Total Liquid Assets	₩276.63 Million	0.12%

Asset Resilience Insights

Limited Liquidity: Hyundai Pharm maintains only 0.12% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hyundai Pharm Industry Peers by Asset Resilience Ratio

Compare Hyundai Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Hyundai Pharm (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Hyundai Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-11-30	0.16%	₩267.91 Million ≈ $181.56K	₩163.22 Billion ≈ $110.61 Million	-0.01pp
2024-11-30	0.17%	₩271.73 Million ≈ $184.15K	₩156.40 Billion ≈ $105.99 Million	-1.40pp
2023-11-30	1.58%	₩2.44 Billion ≈ $1.65 Million	₩154.63 Billion ≈ $104.79 Million	-0.78pp
2022-11-30	2.36%	₩4.27 Billion ≈ $2.89 Million	₩181.16 Billion ≈ $122.77 Million	+2.00pp
2021-11-30	0.35%	₩580.10 Million ≈ $393.13K	₩163.86 Billion ≈ $111.04 Million	-4.20pp
2020-11-30	4.55%	₩7.17 Billion ≈ $4.86 Million	₩157.50 Billion ≈ $106.74 Million	+4.17pp
2013-11-30	0.38%	₩543.24 Million ≈ $368.14K	₩143.40 Billion ≈ $97.18 Million	+0.15pp
2012-11-30	0.23%	₩343.24 Million ≈ $232.61K	₩149.90 Billion ≈ $101.59 Million	+0.01pp
2011-11-30	0.22%	₩343.24 Million ≈ $232.61K	₩156.95 Billion ≈ $106.36 Million	--

pp = percentage points

About Hyundai Pharm

KO:004310 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$170.76 Million

₩251.97 Billion KRW

Market Cap Rank

#17250 Global

#673 in Korea

Share Price

₩8150.00

Change (1 day)

-4.12%

52-Week Range

₩3415.00 - ₩14340.00

All Time High

₩14340.00